FDA warns against ‘microdosing’ with mushroom chocolates due to heart issues, other health risks

Michael Walter | June 11, 2024 | Cardiovascular Business | Heart Health

According to the FDA, a total of 10 people have been hospitalized due to symptoms associated with these products. They are marketed as a "leading form of microdosing."Diamond Shruumz microdosing chocolate bars cookie butter flavor.

The U.S. Food and Drug Administration (FDA) is warning Americans not to “eat, sell or serve” mushroom-laced chocolates sold by Diamond Shruumz. Sickness and hospitalizations after eating these products have been reported in multiple states. Common symptoms include abnormal heart rates, seizures, central nervous system depression, agitation, hypertension, hypotension, nausea and vomiting.

These chocolate bars, cones and gummies, marketed as a “leading form of microdosing,” are sold throughout the United States in smoke/vape shops and other retailers that sell products containing CBD and other hemp-related substances.

According to a new advisory from the FDA, Centers for Disease control and Prevention and America’s Poison Centers, a total of 12 illnesses have been reported in eight different states: Alabama, Arizona, Indiana, Kentucky, Missouri, Nevada, Pennsylvania and South Carolina. Ten of those patients were hospitalized due to their symptoms.

“This product may appeal to children and teenagers as it is marketed as a candy,” the FDA said in its safety warning. “Parents and caregivers should consider discussing the information in this advisory with their children and take extra care to avoid this product being consumed by younger people.”Diamond Shruumz mushroom chocolates microdosing

Various Diamond Shruumz products.

“This product may appeal to children and teenagers as it is marketed as a candy,” the federal agency said in its warning. “Parents and caregivers should consider discussing the information in this advisory with their children and take extra care to avoid this product being consumed by younger people.”

Diamond Shruumz claims microdosing can help “enhance cognitive function,” “improve emotional well-being,” “boost immune health” and “improve physical health.”

“Delve into the world of microdosing by starting with two of our enticing gummies or chocolate squares,” according to the company’s website. “This modest yet effective dosage is crafted to provide a subtle yet noticeable elevation in energy levels, accompanied by a touch of natural stress relief.”

Another common artificial sweetener linked to higher risk of heart attack, stroke

Mediterranean diet helps women live longer, reducing heart disease and cancer risks

World Health Organization urges countries to limit salt intake to reduce risk of CVD, hypertension

Sex, energy drinks and vaccines among the many topics planned for preventive cardiology conference

Processed meats, energy drinks, coconut oil and 5 other popular foods that can damage the heart

Energy drinks may damage the heart, researchers warn—should the FDA get involved?

Young marijuana users face increased risk of stroke

Michael Walter, Managing Editor

Michael has more than 19 years of experience as a professional writer and editor. He has written at length about cardiology, radiology, artificial intelligence and other key healthcare topics.

Around the web

Health Exec

Major association of physicians presents itself as a go-to alternative vs. the government on vaccine expertise

One of the most formidable societies of medical professionals in the U.S. is going toe-to-toe with Robert F. Kennedy’s HHS over changing vaccination recommendations.

Health Exec

Tom Price: Medical residency slots need to expand to combat physician shortages

Tom Price, MD, former secretary of Health and Human Services (HHS), said one way to address the growing shortage of physicians is to expand medical resident positions, but these are tied to Medicare spending so alternative means may be needed.

Health Imaging

Tariffs will have a significant impact on the nuclear imaging supply chain in the US

"Domestic radiopharmaceutical suppliers, who receive isotopes from abroad, would be impacted by price changes and uncertainty caused by additional tariffs,” SNMMI President Cathy Cutler, PhD, wrote in a letter to the U.S. Department of Commerce this week.